Navigating Safely Through The Pandemic
By Stephen LeahySep 2 2020 (IPS-Partners) Having reported on SARS, Ebola, Bird Flu (H5N1) outbreaks, as well as writing about efforts to combat HIV, I was horrified by what was going on in Wuhan, China last Jan mainly because of how fast this new SARS-CoV-2 virus spread. By early Feb it seemed likely there’d be a global pandemic and by the end of Feb I started to freak out as the pandemic took hold. I’ve never been to Wuhan or China nor seen anyone who had; and I hadn’t travelled any where recently. It was nearly impossible for me to have encountered the virus but that didn’t keep me from getting si...
Source: IPS Inter Press Service - Health - September 2, 2020 Category: International Medicine & Public Health Authors: Stephen Leahy Tags: Health Humanitarian Emergencies Source Type: news

Exclusive: The Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - August 25, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

Exclusive: The Chinese Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Science - August 25, 2020 Category: Science Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

Exclusive: The Chinese Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - August 25, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

Vaccine additives can enhance immune flexibility -- Implications for flu and SARS-CoV-2
(Emory Health Sciences) A vaccine additive known as an adjuvant can enhance responses to a vaccine containing the exotic avian flu virus H5N1, so that both rookie and veteran elements of the immune response are strengthened, according to results from an Emory Vaccine Center study. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 16, 2020 Category: Infectious Diseases Source Type: news

FDA accepts Roche ’s New Drug Application for Xofluza (baloxavir marboxil) for the treatment of influenza in children
Basel, 27 March  2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) as well as two supplemental New Drug Applications (sNDA) for Xofluza® (baloxavir marboxil). The FDA accepted a NDA for a new formulation of Xofluza as one-dose granules for oral suspension (2 mg/mL), potentially offering a more convenient option for children and those who have difficulty swallowing. In addition, the application seeks approval of Xofluza for the treatment of acute uncomplicated influenza in otherwise healthy children aged one to l ess th...
Source: Roche Investor Update - March 27, 2020 Category: Pharmaceuticals Source Type: news

Trump ’s State of Emergency Is an Admission of Failure by the U.S. Government
President Donald Trump’s declaration of a national emergency is designed to speed federal support to parts of America that are struggling to prepare for a coming surge of COVID-19 cases, unlocking $50 billion in aid, giving hospitals and doctors more freedom to handle a potential tsunami of sick patients and scrambling to make tests available. In a Rose Garden press conference Friday, Trump presented the emergency measures as proof that, “No nation is more prepared or more equipped to face down this crisis.” But for epidemiologists, medical experts and current and former U.S. public health officials, the ...
Source: TIME: Health - March 13, 2020 Category: Consumer Health News Authors: W.J. Hennigan Tags: Uncategorized COVID-19 Source Type: news

Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity
Current influenza vaccines only confer protection against homologous viruses. We synthesized pulmonary surfactant (PS)–biomimetic liposomes encapsulating 2',3'-cyclic guanosine monophosphate–adenosine monophosphate (cGAMP), an agonist of the interferon gene inducer STING (stimulator of interferon genes). The adjuvant (PS-GAMP) vigorously augmented influenza vaccine–induced humoral and CD8+ T cell immune responses in mice by simulating the early phase of viral infection without concomitant excess inflammation. Two days after intranasal immunization with PS-GAMP–adjuvanted H1N1 vaccine, strong cross-p...
Source: ScienceNOW - February 20, 2020 Category: Science Authors: Wang, J., Li, P., Yu, Y., Fu, Y., Jiang, H., Lu, M., Sun, Z., Jiang, S., Lu, L., Wu, M. X. Tags: Immunology, Microbiology, Online Only r-articles Source Type: news

Audenz ((Influenza A (H5N1) Monovalent Vaccine, Adjuvanted) Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 14, 2020 Category: Drugs & Pharmacology Source Type: news

Audenz ((Influenza A (H5N1) Monovalent Vaccine, Adjuvanted) Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 12, 2020 Category: Drugs & Pharmacology Source Type: news

How Our Modern World Creates Outbreaks Like Coronavirus
“Everyone knows that pestilences have a way of recurring in the world,” observes Albert Camus in his novel The Plague. “Yet somehow we find it hard to believe in ones that crash down on our heads from a blue sky. There have been as many plagues as wars in history; yet plagues and wars always take people by surprise.” Camus was imagining a fictional outbreak of plague in 1948 in Oran, a port city in northwest Algeria. But at a time when the world is reeling from a very real microbial emergency sparked by the emergence of a novel coronavirus in Wuhan, central China, his observations are as pertinent a...
Source: TIME: Health - February 7, 2020 Category: Consumer Health News Authors: Mark Honigsbaum Tags: Uncategorized 2019-nCoV health ideas Source Type: news

Global Solidarity, Collaboration and Urgent Action Needed to Defeat the New Coronavirus Outbreak
Once in a very rare while, a single, serious challenge consumes the attention of the entire world. We are living through one such period today as countries and communities come together to end the new coronavirus outbreak. This virus, provisionally known as the “2019-novel coronavirus,” has, as of 3 February 2020, spread to 24 countries, with over 17,000 people being infected to date, 99% of them in China. The limited numbers of cases elsewhere around the world – just 153 so far – show that efforts to contain the virus in China are curbing its global spread, alongside the detection and clinical care...
Source: TIME: Health - February 4, 2020 Category: Consumer Health News Authors: Dr Tedros Adhanom Ghebreyesus Tags: Uncategorized health ideas Source Type: news

FDA Approves Novel Pandemic Influenza Vaccine FDA Approves Novel Pandemic Influenza Vaccine
Audenz (Seqirus) is the first and only adjuvanted, cell-based pandemic vaccine to provide active immunization against the influenza A virus H5N1 strain.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 4, 2020 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news

First childhood flu helps explain why virus hits some people harder than others
Why are some people better able to fight off the flu than others? Part of the answer, according to a new study, is related to the first flu strain we encounter in childhood.Scientists from UCLA and the University of Arizona have found that people ’s ability to fight off the flu virus is determined not only by the subtypes of flu they have had throughout their lives, but also by the sequence in which they are been infected by the viruses. Their study is published in the open-access journal PLoS Pathogens.The research offers an explanation for why some people fare much worse than others when infected with the...
Source: UCLA Newsroom: Health Sciences - February 4, 2020 Category: Universities & Medical Training Source Type: news

First childhood flu helps explain why virus hits some people harder than others
Editor ’s note: This news release was updated March 3 to include a new link to the study about COVID-19 and to reflect that the study has been accepted by the journal eLife. The release was previously updated Feb. 5 to include new comments from Professor James Lloyd-Smith about screening practices use d by public health officials. Why are some people better able to fight off the flu than others? Part of the answer, according to a new study, is related to the first flu strain we encounter in childhood.Scientists from UCLA and the University of Arizona have found that people ’s ability to figh...
Source: UCLA Newsroom: Health Sciences - February 4, 2020 Category: Universities & Medical Training Source Type: news

FDA Approves Audenz (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted) as First-Ever Adjuvanted, Cell-Based Pandemic Influenza A (H5N1) Vaccine
HOLLY SPRINGS, N.C., Feb. 3, 2020 /PRNewswire/ -- Seqirus, a global leader in influenza prevention and pandemic response, today announced that the U.S. Food and Drug Administration (FDA) has approved Audenz™ (Influenza A (H5N1) Monovalent... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 3, 2020 Category: Drugs & Pharmacology Source Type: news

Bird flu identified in Suffolk
27,000 chickens will be culled at a commercial chicken farm in Mid Suffolk where disease identified Related items fromOnMedica Pandemic flu death toll could be 15 times higher More investment needed to prevent new pandemics Texting can improve flu jab uptake Adjuvanted trivalent flu vaccine best option for over-65s UK population took fewest steps to prevent spread of swine flu (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 11, 2019 Category: UK Health Source Type: news

Vicki Gregory obituary
My sister-in-law, Vicki Gregory, who has died of cancer aged 51, was an international expert in influenza surveillance and research.As a stalwart of theWorldwide Influenza Centre at theFrancis Crick Institute in London, Vicki was held in high regard by colleagues around the globe. With her wealth of knowledge and experience, notably during bird flu outbreaks, she collaborated with many of the laboratories of theWorld Health Organization (WHO)’s influenza response system.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - October 23, 2019 Category: Science Authors: Gillian Malins Tags: Medical research Flu Science Society Vaccines and immunisation Punk Source Type: news

Pandemics and Emerging Diseases
Source: U.S. Food and Drug Administration (FDA). Published: 3/28/2019. This web page provides pandemic influenza information in general, and specifically about 2009 H1N1 (Swine) Flu Virus (Biologics); Influenza Virus Vaccine, H5N1 (for National Stockpile); and Questions and Answers about H5N1 Influenza Virus Vaccine, manufactured by Sanofi Pasteur, Inc. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - March 28, 2019 Category: International Medicine & Public Health Source Type: news

Could CRISPR Diagnostics Provide a Valuable Weapon in the Fight against Pandemic Flu?
The flu season is up and running in the Northern Hemisphere, and early signs in both the United States and Europe are that the effects might not be quite as severe as the brutal 2017/18 season. The United States is predominantly seeing H1N1 circulating, while monitoring in Europe has identified co-circulation of H1N1 and H3N2—both varieties of Influenza A that should be covered by the seasonable vaccine. What if they weren’t though? Influenza A can be found in both human and animal populations, and it evolves rapidly through genetic mutation. Each year many humans rely on their country&a...
Source: MDDI - March 8, 2019 Category: Medical Devices Authors: Paul Wilkins Tags: IVD Source Type: news

Eb144/conf./10
Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits Draft decision proposed by Secretariat with amendments by Member States (Source: WHO Governing Body Documentation)
Source: WHO Governing Body Documentation - January 31, 2019 Category: International Medicine & Public Health Source Type: news

EXPOSED: Vaccine deep state plot to seize NaturalNews.com domain and criminalize all speech that questions vaccine propaganda
(Natural News) The World Health Organization, a criminal cartel front for the vaccine industry, has just declared war on the so-called “anti-vax” movement. The W.H.O. is the same group that spiked vaccines given to women in Africa with abortion / infertility drugs. The W.H.O. is also the same fraudulent group that falsely declared H5N1 bird... (Source: NaturalNews.com)
Source: NaturalNews.com - January 20, 2019 Category: Consumer Health News Source Type: news

Mass vaccination for influenza a failed strategy, scientists admit... it simply doesn't reduce influenza-related hospital admissions at all
(Natural News) Mass vaccination against the pandemic influenza A/H1N1 infection fell short on expected results, according to a study published in the British Medical Journal. Researchers examined a cohort of 388,069 patients younger than 65 years old, who were given the H1N1 vaccination between November 2009 and January 2010 when the transmission of pandemic influenza was... (Source: NaturalNews.com)
Source: NaturalNews.com - January 15, 2019 Category: Consumer Health News Source Type: news

Demystifying Medicine 2019
Source: National Institutes of Health (NIH). Published: 1/8/2019. This one-hour, 48-minute presentation discusses the history of pandemics, their challenges, and the next influenza pandemic. Topics include the role of viral, host, and secondary bacterial factors in influenza pathogenesis; contemporary Avian influenza, and why an HIV vaccine Is essential for ending the HIV/AIDS pandemic. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 10, 2019 Category: International Medicine & Public Health Source Type: news

Demystifying Medicine 2019: The Next Influenza Pandemic and Ending the HIV/AIDS Pandemic: Follow the Science
Source: National Institutes of Health (NIH). Published: 1/8/2019. This one-hour, 48-minute presentation discusses the history of pandemics, their challenges, and the next influenza pandemic. Topics include the role of viral, host, and secondary bacterial factors in influenza pathogenesis; contemporary Avian influenza, and why an HIV vaccine Is essential for ending the HIV/AIDS pandemic. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 10, 2019 Category: International Medicine & Public Health Source Type: news

Nigeria: Global Supplier Dispels Fear Over Ai Vaccine
[Daily Trust] Stakeholders in the poultry industry met to discuss whether the use of vaccination should be adopted against the Avian Influenza disease in the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 27, 2018 Category: African Health Source Type: news

Pandemic Influenza Vaccines: National Deployment and Vaccination Plans
Source: World Health Organization (WHO). Published: 12/2018. This course provides a concise and easily accessible overview of planning considerations for countries to develop and update their national deployment and vaccination plans on the use and deployment of pandemic influenza vaccines. It consists of 10 modules with video presentations and quizzes: (1) Vaccination strategies, (2) Management and organization, (3) Legal and regulatory planning, (4) Communication and information management, (5) Human resources and security, (6) Public communication, (7) Supply chain management, (8) Managing waste, (9) Post-deployment su...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - December 10, 2018 Category: International Medicine & Public Health Source Type: news

Pandemic Influenza Vaccines
Source: World Health Organization (WHO). Published: 12/2018. This course provides a concise and easily accessible overview of planning considerations for countries to develop and update their national deployment and vaccination plans on the use and deployment of pandemic influenza vaccines. It consists of 10 modules with video presentations and quizzes: (1) Vaccination strategies, (2) Management and organization, (3) Legal and regulatory planning, (4) Communication and information management, (5) Human resources and security, (6) Public communication, (7) Supply chain management, (8) Managing waste, (9) Post-deployment su...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - December 10, 2018 Category: International Medicine & Public Health Source Type: news

The Critical Role EMS Plays in Fighting the Flu
Influenza has been impacting public health on a global scale since the beginning of recorded history. Influenza, also known as the “flu,” has numerous organizations committed to public health research, developing vaccines, and educating on best practices to prepare for the upcoming flu season. By gaining an understanding of the flu through history, virology, and how it impacts our society, we can have a better appreciation for the commitment that’s involved with combating the flu. What Is Influenza (and What’s Not)? The eyes of an epidemiologist can twitch for a variety of reasons, one of them being...
Source: JEMS Special Topics - November 8, 2018 Category: Emergency Medicine Authors: Morgan K. Anderson, MPH Tags: Exclusive Articles Operations Source Type: news

Matter: How to Turbocharge Flu Protection (Llamas Required)
A giant antibody created in the laboratory shielded mice against dozens of flu strains, offering new hope against a winter misery. (Source: NYT Health)
Source: NYT Health - November 1, 2018 Category: Consumer Health News Authors: CARL ZIMMER Tags: Influenza Mice Vaccination and Immunization Antibodies Avian Influenza Immune System Viruses Epidemics Deaths (Fatalities) Genetic Engineering Science (Journal) Joost Kulkman Llamas Source Type: news

Matter: How to Turbocharge the Flu Shot (It Involves Llamas)
A giant antibody created in the laboratory shielded mice against dozens of flu strains, offering hope for better protection in humans. (Source: NYT Health)
Source: NYT Health - November 1, 2018 Category: Consumer Health News Authors: CARL ZIMMER Tags: Influenza Mice Vaccination and Immunization Antibodies Avian Influenza Immune System Viruses Epidemics Deaths (Fatalities) Genetic Engineering Science (Journal) Joost Kulkman Llamas Source Type: news

Matter: How to Turbocharge the Flu Shot
A giant antibody created in the laboratory protected mice against dozens of flu strains, offering hope for better protection in humans. (Source: NYT Health)
Source: NYT Health - November 1, 2018 Category: Consumer Health News Authors: CARL ZIMMER Tags: Influenza Mice Vaccination and Immunization Antibodies Avian Influenza Immune System Viruses Epidemics Deaths (Fatalities) Genetic Engineering Science (Journal) Joost Kulkman Llamas Source Type: news

Encourage Your Scleroderma Patients to Get Influenza Vaccine Encourage Your Scleroderma Patients to Get Influenza Vaccine
An important new study suggests that the adjuvant-free pandemic influenza A vaccine is safe and effective in patients with scleroderma.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 29, 2018 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Q & A with Dr Ann Moen: How influenza preparedness helps fight other infectious diseases
Capacity building for influenza is critical because if you can prepare for and respond to flu outbreaks or respiratory events, you learn and practice for responses to other emerging diseases. Flu is not a sporadic outbreak like Ebola or Zika. It is always there, so there is always something to practice with and keep skills sharp. Because flu is a continual threat there is a lot of learning that goes on which also supports work on other emerging diseases. It ’s like the basic architecture for capacity building in all areas. For example, you can practice your communications for responding to outbreaks and better unders...
Source: WHO Feature Stories - October 10, 2018 Category: International Medicine & Public Health Tags: immunization [subject], vaccination, influenza [subject], flu, seasonal influenza, pandemic influenza Source Type: news

Topical cream tested as way to enhance bird flu vaccine
A clinical trial is underway to determine the effectiveness of a topical cream to enhance the immune response to a " pre-pandemic " influenza vaccine. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 6, 2018 Category: Consumer Health News Source Type: news

Clinical trial testing topical cream plus influenza vaccine in progress
(NIH/National Institute of Allergy and Infectious Diseases) A Phase 1 clinical trial examining whether a topical cream can enhance the immune response conferred by a 'pre-pandemic' influenza vaccine is underway at Baylor College of Medicine, a Vaccine and Treatment Evaluation Unit (VTEU) funded by NIAID. Investigators are evaluating whether imiquimod cream, commonly used to treat genital warts and certain skin cancers, can boost the body's immune response to an H5N1 influenza vaccine. The trial is enrolling 50 healthy adults ages 18-50 years. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 5, 2018 Category: Infectious Diseases Source Type: news

China Has Withheld Samples of a Dangerous Flu Virus
Despite an international agreement, U.S. health authorities still have not received H7N9 avian flu specimens from their Chinese counterparts. (Source: NYT Health)
Source: NYT Health - August 27, 2018 Category: Consumer Health News Authors: EMILY BAUMGAERTNER Tags: Avian Influenza China Vaccination and Immunization International Trade and World Market Epidemics Source Type: news

NIAID dcientists create 3D structure of 1918 influenza virus-like particles
(NIH/National Institute of Allergy and Infectious Diseases) Virus-like particles (VLPs) are protein-based structures that mimic viruses and bind to antibodies. Because VLPs aren't infectious, they show promise as vaccine platforms for many viral diseases, including influenza. Since details about influenza VLPs are scant, a team of researchers developed a 3D model based on the 1918 H1 pandemic influenza virus. The research, conducted by NIAID scientists, could benefit VLP vaccine projects, targeting a range of viruses from HIV to Ebola and SARS coronavirus. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 11, 2018 Category: Infectious Diseases Source Type: news

New & Resurgent Infectious Diseases Can Have Far-reaching Economic Repercussions
DAVID E. BLOOM is the Clarence James Gamble Professor of Economics and Demography, DANIEL CADARETTE is a research assistant, and JP SEVILLA is a research associate, all at Harvard University’s T.H. Chan School of Public Health.By David E. Bloom, Daniel Cadarette and JP SevillaWASHINGTON DC, Jul 3 2018 (IPS)Infectious diseases and associated mortality have abated, but they remain a significant threat throughout the world.We continue to fight both old pathogens, such as the plague, that have troubled humanity for millennia and new pathogens, such as human immunodeficiency virus (HIV), that have mutated or spilled over ...
Source: IPS Inter Press Service - Health - July 3, 2018 Category: International Medicine & Public Health Authors: David E. Bloom and JP Sevilla Tags: Active Citizens Development & Aid Economy & Trade Global Headlines Health TerraViva United Nations Source Type: news

Progress in Vaccine-Preventable and Respiratory Infectious Diseases-First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006-2015
During its first 10 years (2006-2015), NCIRD worked with partners to improve preparedness and response to pandemic influenza and other emergent respiratory infections, provide an evidence base for addition of 7 newly recommended vaccines, and modernize vaccine distribution. (Source: PHPartners.org)
Source: PHPartners.org - May 30, 2018 Category: International Medicine & Public Health Source Type: news

Polish firm sued over tricking homeless into flu vaccine test
A company in Poland has been charged for tricking homeless people into taking part in a test of a bird flu vaccine. (Source: CBC | Health)
Source: CBC | Health - March 22, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

University of Maryland School of Medicine experts lead trial on avian flu vaccine
(University of Maryland School of Medicine) Vaccine experts at the University of Maryland School of Medicine have begun multiple clinical trials of vaccines designed to protect against H7N9, an avian influenza virus that was first reported in humans in 2013 in China. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 22, 2018 Category: International Medicine & Public Health Source Type: news

Polish firm sued over tricking homeless into vaccine test
Prosecutors in Poland are suing a private firm accused of tricking homeless people into unwitting participation in bird flu vaccine tests in 2007 (Source: ABC News: Health)
Source: ABC News: Health - March 21, 2018 Category: Consumer Health News Tags: Health Source Type: news

UAB approved to test avian flu vaccines
UAB ’s School of Medicine’s Alabama Vaccine Research Clinic has been selected as a national trial site to test a new avian flu vaccine. The clinic is one of four national trial sites to test a candidate for the H7N9, a strain of the avian influenza.  The trial is sponsored by the National Instit ute of Allergy and Infectious Disease, part of the National Institutes of Health, with the purpose of having an effective vaccine ready for any future H7N9 pandemic. “We are excited for the opportunity… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - March 19, 2018 Category: Health Management Authors: Tyler Patchen Source Type: news

NIH approves clinical trials for vaccine against avian influenza
A federal agency has approved two clinical Phase 2 trials to vaccinate for H7N9, a strain of avian influenza that has not reached humans in the United States. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 16, 2018 Category: Consumer Health News Source Type: news

CDC seeks new labs for bioterror pathogens to replace aging facility
ATLANTA — Inside a complex of special government labs, scientists in full-body protective suits work with some of the world’s deadliest pathogens: Ebola, smallpox and certain strains of bird flu. Many of the organisms have no treatment or vaccine, so the labs housed in this facility on the sprawling campus of the Centers for Disease […]Related:Flu cases fall for the first time this awful influenza seasonCDC warns about salmonella infections traced to kratomHere’s what you should know about the flu season this year (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - February 23, 2018 Category: Consumer Health News Source Type: news

World Health Organization: 142nd Session of the Executive Board
World Health Organization. 02/2018 This Web page provides information, materials, and videos from the 142nd session of the World Health Organization Executive Board, held on January 22-27, 2018. It provides links to the agenda, and to documentation that includes reports on Public Health Preparedness and Response; Health, Environment and Climate Change; and Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - February 15, 2018 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

How Effective Is the 2018 Flu Shot? Here ’s What You Should Know
Vaccination has been recommended for decades as the best way to protect yourself against flu, but it’s no silver bullet. The shot’s effectiveness varies from year to year, depending on the closeness of the match between that season’s viruses and the vaccine, which is usually reformulated each year. This winter in North America, its performance has been especially poor, leaving people more vulnerable to a virus that’s caused a spike in hospitalizations and deaths. In Hong Kong, schools are starting their Chinese New Year holiday earlier amid a flu epidemic that has claimed more than 100 lives in the ...
Source: TIME: Health - February 7, 2018 Category: Consumer Health News Authors: Jason Gale / Bloomberg Tags: Uncategorized Bloomberg health onetime Source Type: news

How Effective Is the 2018 Flu Shot? Here ’s What You Should Know
Vaccination has been recommended for decades as the best way to protect yourself against flu, but it’s no silver bullet. The shot’s effectiveness varies from year to year, depending on the closeness of the match between that season’s viruses and the vaccine, which is usually reformulated each year. This winter in North America, its performance has been especially poor, leaving people more vulnerable to a virus that’s caused a spike in hospitalizations and deaths. In Hong Kong, schools are starting their Chinese New Year holiday earlier amid a flu epidemic that has claimed more than 100 lives in the ...
Source: TIME: Science - February 7, 2018 Category: Science Authors: Jason Gale / Bloomberg Tags: Uncategorized Bloomberg health onetime Source Type: news

Eb142(r7)
Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits (Source: WHO Governing Body Documentation)
Source: WHO Governing Body Documentation - January 27, 2018 Category: International Medicine & Public Health Source Type: news